Identification and Characterization of 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-Activated Receptor δ (PPARδ) Antagonist-Reference-Cited by-同舟云学术

Identification and Characterization of 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-Activated Receptor δ (PPARδ) Antagonist

Published:2010-02-03 Issue:4 Volume:53 Page:1857-1861
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Shearer Barry G.¹,Wiethe Robert W.¹,Ashe Adam¹,Billin Andrew N.²,Way James M.²,Stanley Thomas B.³,Wagner Craig D.³,Xu Robert X.⁴,Leesnitzer Lisa M.⁵,Merrihew Raymond V.⁵,Shearer Todd W.⁶,Jeune Michael R.⁶,Ulrich John C.⁶,Willson Timothy M.⁷

Affiliation:

1. Department of Metabolic Chemistry

2. Discovery Technology Group

3. Department of Analytical Biochemistry and Biophysics

4. Department of Computational and Structural Sciences

5. Department of Screening and Compound Profiling

6. Department of Drug Metabolism and Pharmacokinetics

7. Discovery Medicinal Chemistry

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine